InsiderTrades

Form 4 for MRSH Marsh McLennan

Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001127602-25-007860 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-04 2025-03-03 MRSH Doyle John Q Pres, CEO S - Sale+OE $237.05 -21.1K 87.7K -19% -$5.00M
DM 2025-03-04 2025-02-28+ MRSH Doyle John Q Pres, CEO M - OptEx $28.00 +47.5K 101.2K +89% +$1.33M
D 2025-03-04 2025-02-28 MRSH Doyle John Q Pres, CEO F - Tax $233.74 -13.5K 87.7K -13% -$3.15M
DM 2025-03-04 2025-02-28+ MRSH Doyle John Q Pres, CEO M - OptEx $0.00 -47.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-03 S D 21,080 $237.05 87,681.02 D — —
2 Common Common Stock 2025-03-03 M A 21,080 $63.09 108,761.02 D — —
3 Common Common Stock 2025-02-28 F D 13,491 $233.74 87,681.02 D — —
4 Common Common Stock 2025-02-28 M A 26,426 $0.00 101,172.02 D — —
5 Derivative Stock Options (Right to Buy) 2025-03-03 M D 21,080 $0.00 63,238 D $63.09 · — to 2026-04-30 21,080 Common Stock (F5) These options were granted on May 1, 2016 and vested in four equal annual installments on May 1 of 2017, 2018, 2019 and 2020.
6 Derivative Restricted Stock Units 2025-02-28 M D 26,426 $0.00 0 D — · — to — 26,426 Common Stock (F3) The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis. (F4) Not applicable.